-
Zhittya close to getting approval for human clinical trials
Zhittya believes vascular disruption and micro-vessel disease in the brain is a major contributor to neurodegenerative diseases, such as Parkinson’s disease. They hope to start human clinical trials in 2019.
The first place hey will post the FDA-authorized inclusion and exclusion criteria will be on Zhittya’s YouTube channel. if you are not subscribed to Zhittya’s YouTube channel you can go to:
https://www.youtube.com/channel/UCJxXe8QTf5PoqpZARgL3frw
and subscribe by hitting the red button that says “Subscribe”
I think their work has promise. What are your thoughts on their theory?
Log in to reply.